These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11046196)

  • 1. Development of an activity scale for individuals with advanced Parkinson disease: reliability and "on-off" variability.
    Nieuwboer A; De Weerdt W; Dom R; Bogaerts K; Nuyens G
    Phys Ther; 2000 Nov; 80(11):1087-96. PubMed ID: 11046196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trial.
    Siderowf A; McDermott M; Kieburtz K; Blindauer K; Plumb S; Shoulson I;
    Mov Disord; 2002 Jul; 17(4):758-63. PubMed ID: 12210871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
    Parkinson Study Group CALM Cohort Investigators
    Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interrater reliability of the Unified Parkinson's Disease Rating Scale motor examination.
    Richards M; Marder K; Cote L; Mayeux R
    Mov Disord; 1994 Jan; 9(1):89-91. PubMed ID: 8139610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients.
    Hinson VK; Goetz CG; Leurgans S; Fan W; Nguyen T; Hsu A
    Clin Neuropharmacol; 2009; 32(4):189-92. PubMed ID: 19620848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study.
    Parkinson Study Group
    Arch Neurol; 2005 Feb; 62(2):241-8. PubMed ID: 15710852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a scale for rating motor compensations used for reaching in patients with hemiparesis: the reaching performance scale.
    Levin MF; Desrosiers J; Beauchemin D; Bergeron N; Rochette A
    Phys Ther; 2004 Jan; 84(1):8-22. PubMed ID: 14992673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of measurements obtained with the Timed "Up & Go" test in people with Parkinson disease.
    Morris S; Morris ME; Iansek R
    Phys Ther; 2001 Feb; 81(2):810-8. PubMed ID: 11175678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unified Parkinson's disease rating scale motor examination: are ratings of nurses, residents in neurology, and movement disorders specialists interchangeable?
    Post B; Merkus MP; de Bie RM; de Haan RJ; Speelman JD
    Mov Disord; 2005 Dec; 20(12):1577-84. PubMed ID: 16116612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability and validity of the Tinetti Mobility Test for individuals with Parkinson disease.
    Kegelmeyer DA; Kloos AD; Thomas KM; Kostyk SK
    Phys Ther; 2007 Oct; 87(10):1369-78. PubMed ID: 17684089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.
    Nyholm D; Nilsson Remahl AI; Dizdar N; Constantinescu R; Holmberg B; Jansson R; Aquilonius SM; Askmark H
    Neurology; 2005 Jan; 64(2):216-23. PubMed ID: 15668416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral subthalamotomy in Parkinson's disease: initial and long-term response.
    Alvarez L; Macias R; Lopez G; Alvarez E; Pavon N; Rodriguez-Oroz MC; Juncos JL; Maragoto C; Guridi J; Litvan I; Tolosa ES; Koller W; Vitek J; DeLong MR; Obeso JA
    Brain; 2005 Mar; 128(Pt 3):570-83. PubMed ID: 15689366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal study of the motor response to levodopa in Parkinson's disease.
    Clissold BG; McColl CD; Reardon KR; Shiff M; Kempster PA
    Mov Disord; 2006 Dec; 21(12):2116-21. PubMed ID: 17029259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients', doctors', and caregivers' assessment of disability using the UPDRS-ADL section: are these ratings interchangeable?
    Martínez-Martín P; Benito-León J; Alonso F; Catalán MJ; Pondal M; Tobías A; Zamarbide I
    Mov Disord; 2003 Sep; 18(9):985-92. PubMed ID: 14502665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson Disease.
    Goberman AM
    Med Sci Monit; 2005 Mar; 11(3):CR109-16. PubMed ID: 15735562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability and validity of the dynamic gait index in persons with chronic stroke.
    Jonsdottir J; Cattaneo D
    Arch Phys Med Rehabil; 2007 Nov; 88(11):1410-5. PubMed ID: 17964880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selegiline slows the progression of the symptoms of Parkinson disease.
    Pålhagen S; Heinonen E; Hägglund J; Kaugesaar T; Mäki-Ikola O; Palm R;
    Neurology; 2006 Apr; 66(8):1200-6. PubMed ID: 16540603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, open-label, sequential study comparing preferences for carbidopa-levodopa orally disintegrating tablets and conventional tablets in subjects with Parkinson's disease.
    Nausieda PA; Pfeiffer RF; Tagliati M; Kastenholz KV; DeRoche C; Slevin JT
    Clin Ther; 2005 Jan; 27(1):58-63. PubMed ID: 15763606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An interrater reliability study of the Braden scale in two nursing homes.
    Kottner J; Dassen T
    Int J Nurs Stud; 2008 Oct; 45(10):1501-11. PubMed ID: 18395726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.